Orthopedics in North Carolina

Medical Specialties, Inc. (Med Spec) is a leading manufacturer of orthopedic and sports medicine bracing solutions. The company specializes in custom and prefabricated orthotic devices designed for injury prevention, rehabilitation, and performance enhancement across multiple anatomical regions. Product lines include foot and ankle braces, wrist and hand supports, knee stabilizers, elbow and shoulder braces, and back and spine supports. The EVO® line represents their featured product family, with devices such as the EVO Ankle Stabilizer, Wrist Lacer™ II Wrist Support, and DynaTrack™ Plus Patella Stabilizer. Med Spec serves orthopedic clinics, sports medicine facilities, athletic trainers, physical therapists, and healthcare systems. The company operates multiple brands including ASO and Evo, indicating a diversified portfolio of bracing technologies. Manufacturing capabilities support both custom fabrication and mass production. Products are designed for post-operative care, chronic condition management, and athletic performance support.

RAUMEDIC AG is a Germany-based (Helmbrechts) manufacturer specializing in polymer-based medical devices and pharmaceutical components. The company develops and manufactures tubing systems, catheters, cannulas, syringes, and infusion sets for cardiosurgery, cell and gene therapy, drug delivery, enteral feeding, infusion therapy, neuromonitoring, ophthalmology, orthopedics, and traumatology applications. RAUMEDIC operates an in-house online shop for single-use bioprocess equipment and offers comprehensive services including material expertise, product design, prototyping, manufacturing, and regulatory support (product registration guidance). The company maintains competencies across material development, product concept design, precision prototyping, and multiple manufacturing technologies. RAUMEDIC serves hospitals, pharmaceutical manufacturers, and biotech firms globally, with demonstrated commitment to sustainability including development of low-carbon footprint medical consumables. The company is headquartered in Germany with operations indicated in multiple markets.

SutureTech is a medical device manufacturer specializing in advanced tendon and ligament repair solutions. Founded by a surgeon, the company develops innovative orthopedic devices that address critical soft tissue repair challenges across multiple surgical specialties including rotator cuff repair, shoulder and elbow surgery, hand surgery, trauma surgery, and sports medicine. The company's flagship product, RapidFix™, is an all-suture dual anchor mattress repair system designed to optimize healing through anatomic repair geometry, large surface-area compression, and minimal gap formation. RapidFix™ features a user-friendly, low-profile instrument that minimizes operative time and complexity while supporting faster patient recovery. The platform technology extends beyond standard rotator cuff repairs to include remplissage, in-situ partial tendon repair, graft augmentation to tendon/bone fixation, and non-shoulder tendon and ligament repairs. SutureTech's devices integrate rigorous research, clinical expertise, and patented biomechanical designs to meet the highest medical standards for hospital centers, surgical teams, and patients.

Gilero is a contract development and manufacturing organization (CDMO) specializing in the design, development, and manufacturing of medical devices and drug delivery systems. Founded in 2002 and headquartered in Durham, North Carolina, Gilero became part of the Sanner Group in September 2024, expanding its global capabilities. The company offers comprehensive end-to-end services across the entire product lifecycle, including design and engineering, concept development, prototyping, clinical and small-batch manufacturing, electromechanical systems integration, human factors and usability engineering, regulatory affairs support, and full-scale contract manufacturing. Gilero operates over 300,000 square feet of ISO-certified cleanroom manufacturing facilities (ISO Class 7 and 8) across North America, Europe, and Asia, enabling both small-batch and high-volume production. With more than 130 engineers and regulatory experts, Gilero supports device development from initial concept through commercialization, serving diverse therapeutic areas including closed-system drug transfer devices, surgical instruments, ocular implant delivery systems, and hemostasis devices. The company combines expertise in biomedical, mechanical, electrical, and software engineering to deliver scalable manufacturing solutions tailored to client specifications and regulatory requirements.